# Clinical Interconnectivity & Global Grids

In network analysis of global health research, does Africa's connectivity to the international trial network reflect genuine integration or structural dependency? This graph-theory analysis evaluated collaborator relationships for 23,873 African trials using ClinicalTrials.gov sponsor and collaborator metadata to map directional partnership edges. Investigators reported the ratio of incoming-to-outgoing research edges as the primary estimand for network sovereignty. Africa exhibited a net-importer topology with approximately 3.2 incoming edges (foreign sponsors conducting trials in Africa) for every outgoing edge (African institutions participating in foreign-located trials). The United States showed a balanced ratio of 1.1, while China demonstrated net exporter status at 0.7, indicating sovereign research production exceeding foreign participation. Africa's high connectivity score of 0.9 masked dependency rather than sovereignty since eighty percent of edges originated from Northern institutions. These findings reframe Africa's network position from integration to colonisation. Interpretation is limited by the difficulty of determining the true direction of intellectual contribution within collaborative relationships.

## References

1. Drain PK, et al. "Global migration of clinical trials." Nat Rev Drug Discov. 2018;17:765-766.
2. Alemayehu C, et al. "Behind the mask of the African clinical trials landscape." Trials. 2018;19:519.

## Note Block

- Type: research
- App: https://mahmood726-cyber.github.io/africa-e156-students/health-disease/dashboards/clinical-interconnectivity.html
- Code: https://github.com/mahmood726-cyber/africa-e156-students/blob/master/health-disease/code/clinical-interconnectivity.py
- Data: ClinicalTrials.gov API v2
- Date: 2026-04-05